title: Long-acting growth hormones produced by conjugation with polyethylene glycol.
abstract: Derivatives of human growth hormone (hGH) of increasing size were produced by reaction with the N-hydroxysuccinimide ester of polyethylene glycol-5000 (PEG5000), a 5-kDa reagent that selectively conjugates to primary amines. By adjusting the reaction conditions and purification procedure, it was possible to isolate hGH derivatives containing up to seven PEG moieties that altered the Stokes radius and thereby the effective molecular masses of the unmodified hormone from 22 to 300 kDa. Fortunately, the most reactive amines were ones that did not lie in either of the two sites important for receptor binding. Nonetheless, increasing the level of PEG modification linearly reduced the affinity of hGH for its receptor and increased the EC50 in a cell-based assay up to 1500-fold. Most of the reduction in affinity was the result of slowing the association rate for the receptor. The clearance rate of hGH in rats was inversely proportional to effective molecular weight and closely fit a filtration model. We have tested the potency of these analogs by injecting them daily or every 6 days into hypophysectomized rats and determining the effects on body and organ growth. The efficacy of these analogs was optimal for hGH conjugated with 5 eq of PEG5000, and the potency was increased by about 10-fold compared with unmodified hGH. Such PEG-hGH derivatives show promise as long-acting alternatives to daily injections of hGH. More generally these studies show that improving hormone clearance properties, even at the expense of reducing receptor binding affinity, can lead to dramatic increases in hormone efficacy.
authors.affiliation: Department of Endocrine Research, Genentech, Inc., South San Francisco, California 94080, USA.
authors.forename: R
authors.initials: R
authors.lastname: Clark
authors.forename: K
authors.initials: K
authors.lastname: Olson
authors.forename: G
authors.initials: G
authors.lastname: Fuh
authors.forename: M
authors.initials: M
authors.lastname: Marian
authors.forename: D
authors.initials: D
authors.lastname: Mortensen
authors.forename: G
authors.initials: G
authors.lastname: Teshima
authors.forename: S
authors.initials: S
authors.lastname: Chang
authors.forename: H
authors.initials: H
authors.lastname: Chu
authors.forename: V
authors.initials: V
authors.lastname: Mukku
authors.forename: E
authors.initials: E
authors.lastname: Canova-Davis
authors.forename: T
authors.initials: T
authors.lastname: Somers
authors.forename: M
authors.initials: M
authors.lastname: Cronin
authors.forename: M
authors.initials: M
authors.lastname: Winkler
authors.forename: J A
authors.initials: JA
authors.lastname: Wells
mesh_terms: D000818:Animals; D001665:Binding Sites; D002455:Cell Division; D004797:Enzyme-Linked Immunosorbent Assay; D005079:Excipients; D013006:Growth Hormone / Q000138:chemical synthesis* / Q000494:pharmacology; D006207:Half-Life; D006801:Humans; D007016:Hypophysectomy; D007700:Kinetics; D008970:Molecular Weight; D011092:Polyethylene Glycols / Q000737:chemistry*; D011487:Protein Conformation; D051381:Rats; D011986:Receptors, Somatotropin / Q000235:genetics; D013936:Thymidine / Q000378:metabolism; D014162:Transfection; D015430:Weight Gain / Q000187:drug effects
chemical_list: D005079:Excipients; D011986:Receptors, Somatotropin; D011092:Polyethylene Glycols; D013006:Growth Hormone; D013936:Thymidine